Charmacy Pharmaceutical Co., Ltd. (HKG:2289)

Market Cap	786.24M
Revenue (ttm)	4.65B
Net Income (ttm)	52.90M
Shares Out	108.00M
EPS (ttm)	0.49
PE Ratio	14.86
Forward PE	n/a
Dividend	0.49 (6.72%)
Ex-Dividend Date	May 26, 2025

Volume	1,000
Average Volume	50
Open	7.28
Previous Close	5.90
Day's Range	7.28 - 7.31
52-Week Range	5.13 - 8.90
Beta	-0.92
RSI	67.77
Earnings Date	Mar 26, 2026

About Charmacy Pharmaceutical

Charmacy Pharmaceutical Co., Ltd. engages in the pharmaceutical distribution business in the People’s Republic of China. The company distributes western medicines, Chinese patent medicines, healthcare products, and pharmaceutical products to downstream distributors and retail terminals. It also offers pharmaceutical product related consulting services; and operates Charmacy e-Medicine, a B2B e-commerce platform to place orders online, make inquires and payments, etc. The company was formerly known as Chuangmei Pharmaceutical Co., Ltd. and chang...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1984
• Employees: 847
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2289

Financial Performance

In 2024, Charmacy Pharmaceutical's revenue was 4.44 billion, an increase of 0.72% compared to the previous year's 4.40 billion. Earnings were 53.28 million, an increase of 3.78%.

Financial numbers in CNY